MENU
Novo-Nordisk A/S (NVO) Ownership - Who owns Novo-Nordisk A/S?
Industry: @Pharmaceuticals Major
Profile
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
584.45B
P/E Ratio
43.97
Total Cash
62.65B
Projected Growth
1.98
Total Debt
57.06B
Revenue
258B
Risk (Beta)
0.59
Dividend Yield
0.01
Total Cash/Share
14.07
Total Debt/Equity
2.39
Revenue/Share
8.56 USD as % of share price
Fundamentals
NVO
Capitalization
584B
P/E Ratio
43.97
Risk (Beta)
0.59
Dividend Yield
0.01
Total Cash
62.7B
Total Cash/Share
14.07
Total Debt
57.1B
Total Debt/Equity
2.39
Projected Growth (PEG Ratio)
1.98
Revenue/Share (as % of the share price)
8.56%
Revenue
258B
ROE
N/A
Book Value
113B
P/B Ratio
34.97
Cash Flow
N/A
Earnings
20.14
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
446M
Current Ratio
0.94
Current Revenue Per Employee
982674.00
Dividends Per Share - Security
0.00
EBITDA
134B
Float
N/A
Float - Current
N/A
Gross Income Margin
84.90
Revenue To Assets
27.66
Shares Held By Institutions
123B
Shares Outstanding - Current
4.45B
Total Liabilities
257B
Total Volume MTD
N/A
Value
1
Gain YTD
28.399
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of pharmaceutical products
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Pharmaceuticals Major
Address
Novo Alle 1
Phone
+45 44448888
Employees
64319
Web
https://www.novonordisk.com